Enfortumab vedotin-ejfv (ADC)
Enfortumab vedotin-ejfv is an ADC consisting of a Nectin-4-directed antibody and Monomethyl auristatin E (MMAE), suitable for adult patients with locally advanced or metastatic urothelial carcinoma, or who have received programmed cell death protein 1 (PD-1) inhibitor or programmed cell death ligand 1 (PD-L1) inhibitor therapy or neoadjuvant/adjuvant platinum-based chemotherapy for locally advanced or metastatic cancer.
Product Specifications
Product Name Alternative
Padcev, ASG-22ME
Reactivity
Human
Applications
Research Grade Biosimilar
Stability
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks) . Store at -20°C 12 months. Store at -80°C long term.
Endotoxin
Please contact with the lab for this information.
Purity
>90% as determined by SEC.
Form
Liquid
Notes
For research use only. Not suitable for clinical or therapeutic use.
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Mouse Monoclonal Kappa Light Chain Antibody (TB28-2) [Alexa Fluor 350]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
NBP2-34721AF350 0.1 mL
Mouse Monoclonal Kappa Light Chain Antibody (TB28-2) [Alexa Fluor 350]
Ask
View Details 
036583-ML490 100 µL
HIST1H2AA, NT (HIST1H2AA, H2AFR, Histone H2A type 1-A, Histone H2A/r) (MaxLight 490) discontinued
Ask
View Details